Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Receivables - Net (2019 - 2022)

NovaBridge Biosciences (NBP) has disclosed Receivables - Net for 4 consecutive years, with $3.6 million as the latest value for Q4 2022.

  • On a quarterly basis, Receivables - Net rose 148.44% to $3.6 million in Q4 2022 year-over-year; TTM through Dec 2022 was $3.6 million, a 148.44% increase, with the full-year FY2022 number at $3.8 million, up 163.16% from a year prior.
  • Receivables - Net was $3.6 million for Q4 2022 at NovaBridge Biosciences, up from $1.4 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $3.6 million in Q4 2022 to a low of $556172.6 in Q4 2019.
  • A 4-year average of $1.8 million and a median of $1.6 million in 2020 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 215.61% in 2020, then dropped 17.88% in 2021.
  • NovaBridge Biosciences' Receivables - Net stood at $556172.6 in 2019, then skyrocketed by 215.61% to $1.8 million in 2020, then decreased by 17.88% to $1.4 million in 2021, then surged by 148.44% to $3.6 million in 2022.
  • Per Business Quant, the three most recent readings for NBP's Receivables - Net are $3.6 million (Q4 2022), $1.4 million (Q4 2021), and $1.8 million (Q4 2020).